Сегодня 26 сентября 2022
Медикус в соцсетях
Задать вопрос

ЗАДАТЬ ВОПРОС РЕДАКТОРУ РАЗДЕЛА (ответ в течение нескольких дней)

Не публикуется
служит для обратной связи
Антиспам - не удалять!
Ваш вопрос:
Получать ответы и новости раздела
17 мая 2002 00:00   |   Afzal Zaidi, FRCS*a, Vipin Zamvar, FRCS(CTh)a, Fergus Macbeth, FRCRa, Allen R. Gibbs, FRCPathb, Nihal Kulatilake, FRCSa, Eric G. Butchart, FRCSa

Pulmonary blastoma: medium-term results from a regional center

Background. Pulmonary blastomas are rare lung tumors that morphologically resemble fetal pulmonary structure and can exist in two forms, biphasic and monophasic. We reviewed our experience over a 12−year period with emphasis on the clinical features, management, and outcome.
Methods. Patients with a diagnosis of pulmonary blastoma from January 1988 to July 1999 were identified from the database of the Department of Histopathology, Llandough Hospital, Cardiff. Specimens had been obtained from bronchoscopy, fine-needle aspiration, trucut biopsy, and thoracotomy.
Results. Six patients were identified from 2,720 histologically proven lung cancers (0.2%). Median age was 35.5 years and sex ratio was equal. Overall, 4 patients underwent resection and are all alive (median, 43.5 months). Three of these had advanced tumors at presentation (stage IIIb or IV), two of which were successfully downstaged with neoadjuvant chemotherapy, and the third treated with postoperative radiotherapy. Nonresected cases succumbed at a median of 5.5 months.
Conclusions. Although pulmonary blastomas are rare, those affected represent a group of patients with advanced tumors for whom a coordinated approach from both oncologists and surgeons can achieve excellent medium-term results.


Смотри также
17 мая 2002  |  00:05
Cell membrane fluidity and prognosis of lung cancer
Background. Membranes of tumor cells have been found to posses higher fluidity than membranes of nontumor cells. Plasma membrane fluidity is significantly correlated with malignant potential of
17 мая 2002  |  00:05
Neural networks as a prognostic tool of surgical risk in lung resections
Background. Assessment of surgical risk in patients undergoing pulmonary resection is a fundamental goal for thoracic surgeons. Usually used risk indices do not predict the individual outcome.
17 мая 2002  |  00:05
Natriuretic peptides after pulmonary resection
Background. Little is known about alterations in the levels and influence of natriuretic peptide (NP) on cardiopulmonary function after pulmonary resection for lung cancer. This study was designed
17 мая 2002  |  00:05
Outcomes of lung volume reduction surgery followed by lung transplantation: a matched cohort study
Background. Lung volume reduction surgery (LVRS) has been demonstrated to provide symptomatic relief and to improve lung function in patients with end-stage emphysema. The goal of this study was
17 мая 2002  |  00:05
Cystic lung lesions in the pediatric and adult population: surgical experience at the Brompton hospital
Background. Cystic lung lesions are found in the adult and pediatric populations. We present our 19-year experience with such lesions from a single institution. Methods. We retrospectively reviewed